latest news releases from the newsroom
Safetek International Inc.
Safetek Announces New Life Sciences Direction
NEW YORK, May 23, 2005 (PRIMEZONE) -- On May 4, 2005, the Company (Pink Sheets:SFIN) resolved to focus on new technologies in the life sciences and health care fields. Despite the considerable medical advances that have occurred over the last few decades, there still remain major areas of unmet need. To date, Safetek has identified several innovative drug discovery, drug development and medical device technologies that may be used to create effective therapeutics for the treatment of various diseases.
San Diego Gas & Electric
SDG&E Working to Ensure Reliable, Long-Term Natural Gas Supplies at Reasonable Cost
SAN DIEGO, May 23, 2005 (PRIMEZONE) -- San Diego Gas & Electric (SDG&E) is working to ensure its customers have reliable, long-term supplies of reasonably priced natural gas. With domestic gas production not keeping pace with growing demand for natural gas, SDG&E officials say energy conservation, an increased use of renewable energy resources, and new natural gas supplies from non-traditional sources, such as liquefied natural gas (LNG), will be required to meet customers' future energy needs.
Southern California Gas Company
The Gas Company Working to Ensure Reliable, Long-Term Gas Supplies at Reasonable Cost
LOS ANGELES, May 23, 2005 (PRIMEZONE) -- Ensuring a reliable supply of reasonably priced natural gas continues to be a key goal of Southern California Gas Co. (The Gas Company). With domestic gas production not keeping pace with growing demand for natural gas, Gas Company officials say energy conservation, an increased use of renewable energy resources, and new supplies from non-traditional sources, such as liquefied natural gas (LNG), will be required to meet customers' future energy needs.
Megola Announces New Product Trials
CORUNNA, Ontario, May 23, 2005 (PRIMEZONE) -- Megola Inc. (OTCBB:MGOA), a leading environmental solution provider in physical water treatment, microbiological control, wastewater treatment and air purification, announced that it will begin several new product trials over the upcoming months.
Safetek International Inc.
Safetek -- SFIN -- Announces New Director/CEO
NEW YORK, May 23, 2005 (PRIMEZONE) -- On April 19, 2005, the Company announced the election of Dr. Shay Goldstein as new Director and CEO of Safetek International (Pink Sheets:SFIN). Dr. Goldstein brings to Safetek in-depth medical scientific understanding as well as his experience in developing business strategy and managing growing companies. He has held a variety of business development and operational executive positions with numerous biomedical companies. Prior to joining Safetek, Dr. Goldstein spent 3 years in Silicon Valley, California, as the director of Rimed, Ltd., an Israeli based medical devise company specializing in development of advanced Neuro-diagnostic medical equipment. He established the marketing and sales infrastructure of that company in the U.S. and was responsible for growing the market share from 0% to 14% in the first year of operation. During that period Dr. Goldstein also served as a Life Science Consultant for Silicon Ventures. As an advisor to one of the largest organized groups of Angel Investors in the United States, he provided clinical and business analysis for several medical device and biotechnology projects. Prior to that Dr. Goldstein served 2 years as the business development and medical marketing director at Medidactic, Ltd, both in the U.S. and in Israel. At Medidactic, he managed marketing and sales training projects for several leading healthcare companies internationally, including: "Teva" (Israel), "Roche" (Israel), "Taro" (Israel), "Advanced Stent Technologies (USA) and "Corgentech" (USA). Earlier in his career, Dr. Goldstein was a Co-Founder and Manager of a biotechnology Incubator project that developed a biochemical delivery system for treating Neurodegenerative diseases. Dr. Goldstein received his MD and B.Sc in Medical sciences (Cum Laude) degrees from the Technion, Israel Institute of Technology.
Keryx Biopharmaceuticals, Inc.
Keryx Biopharmaceuticals to Present at Needham & Company's Fourth Annual Biotechnology Conference
NEW YORK, May 23, 2005 (PRIMEZONE) -- Keryx Biopharmaceuticals, Inc. (Nasdaq:KERX), announced today that Michael S. Weiss, Chairman and Chief Executive Officer, will present an overview of the Company, including recent clinical results and upcoming milestones at the Needham & Company Fourth Annual Biotechnology Conference in New York City. Mr. Weiss' presentation will take place on Wednesday, May 25, 2005 at 4:00 p.m. Eastern Time in the L'Orangerie Room of the New York Palace Hotel. A live audio webcast of Mr. Weiss' presentation will be available at http://www.wsw.com/webcast/needham11/kerx/. An archived version of the webcast will be available following the conclusion of the live presentation.
SmallCap Sentinel: Looking Within -- Homeland Security Looks to Domestic Sources of Terrorism
IRVINE, Calif., May 23, 2005 (PRIMEZONE) -- A report focusing on one company's efforts in the arena of Homeland Security has been made available to the public through financial courier StockUpTicks.com as the various sources of terrorism are being discussed in the U.S. Senate. Speaking to a Senate panel on Wednesday, senior-level officials of the FBI and the Bureau of Alcohol, Tobacco, Firearms (ATF) and Explosives said growing concern continues over potential domestic terrorist activities from extremist organizations including animal rights and environmental activists, according to a CNN article. Such groups have claimed responsibility for more than 1,200 criminal incidents since 1990 the report stated.